Verona Pharma (VRNA)
(Delayed Data from NSDQ)
$29.99 USD
+0.59 (2.01%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $29.99 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth B Momentum F VGM
Verona Pharma PLC American Depositary Share (VRNA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$36.50 | $38.00 | $34.00 | 24.15% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Verona Pharma PLC American Depositary Share comes to $36.50. The forecasts range from a low of $34.00 to a high of $38.00. The average price target represents an increase of 24.15% from the last closing price of $29.40.
Analyst Price Targets (6 )
Broker Rating
Verona Pharma PLC American Depositary Share currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, six are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/9/2024 | BTIG | Thomas Shrader | Strong Buy | Strong Buy |
8/14/2024 | Piper Sandler | Yasmeen Rahimi | Strong Buy | Strong Buy |
8/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/28/2024 | Truist Securities | Joon Lee | Strong Buy | Strong Buy |
6/27/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Strong Buy | Strong Buy |
6/27/2024 | Canaccord Genuity | Edward H Nash | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 6 |
Average Target Price | $36.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.45 |
VRNA FAQs
Verona Pharma PLC American Depositary Share (VRNA) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Verona Pharma PLC American Depositary Share (VRNA) is $36.50. The current on short-term price targets is based on 4 reports.
The forecasts for Verona Pharma PLC American Depositary Share (VRNA) range from a low of $34 to a high of $38. The average price target represents a increase of $21.71 from the last closing price of $29.99.
The current UPSIDE for Verona Pharma PLC American Depositary Share (VRNA) is 21.71%
Based on short-term price targets offered by six analysts, the average price target for Verona Pharma PLC American Depositary Share comes to $36.50. The forecasts range from a low of $34.00 to a high of $38.00. The average price target represents an increase of 24.15% from the last closing price of $29.40.